USSTOCK.TODAY
Pre-Market
Log in Sign up
Company overview

What Does Park Ha Biological Technologies (BYAH) Do? – Full Overview of Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters

Updated August 14, 2026 · First published April 26, 2026

Park Ha Biological Technologies (BYAH) is a company that operates both its own branded product sales and a franchise business in the Chinese skincare and cosmetics market. Revenue structure, franchise location changes, and the outlook for online sales expansion are the key items to verify in stock-price analysis.

Briefs · earnings · signals, first Subscribe

🏢 What kind of company is Park Ha Biological Technologies?

Park Ha Biological Technologies is a consumer-goods company that develops and sells its own branded skincare and cosmetics products in China. It combines directly operated store management, support for franchise partners, and in-store services that help customers use its products, allowing it to manage the brand experience and sales touchpoints together.

Its core business is the development and sale of Park Ha branded products and the operation of its franchise business. Improvements to products targeting sensitive skin are tied to franchise-partner training and marketing support, and product sales combined with franchise fees form the revenue structure.

💰 How does Park Ha Biological Technologies make money?

Business segmentRevenue shareDescription
Franchise feesMain driverRevenue generated from contracting with and supporting franchise partners.
Product salesKey complementary pillarRevenue generated from the sale of its own skincare and cosmetics products.

Because franchise fees and product sales run side by side, franchise-partner inflows, renewals, and attrition together with consumer demand drive revenue trends. The franchise network can serve as a foundation for brand expansion and training systems, but it can also be sensitive to changes in contract terms or deterioration in store-operating conditions. Product sales are supplemented through in-store services and usage experiences, and the expansion of online sales channels can be viewed as a growth axis that reduces dependence on existing offline touchpoints.

📐 Park Ha Biological Technologies market cap and company size

Market cap is $5.7M and the number of employees has not been disclosed.

Park Ha Biological Technologies is a company that requires looking at how a specific brand, franchise operations, and regional consumer demand interlock. When comparing with peer companies that manufacture and sell personal-care products, differences in product lineup, franchise model, and distribution channel should be examined separately. Capital return policy and financial capacity can change over time, so it is appropriate to verify them based on the most recent filings.

📈 Park Ha Biological Technologies outlook and stock-price trends

1-Year Price Performance
Analyst Consensus
No analyst coverage
Small-cap or newly listed stocks may not have valuation data collected.
52-Week Price Range
$2
Low $2 High $224
vs. low +1.67% vs. high -98.91%

In the short term, franchise-partner renewals, new partner recruitment, and the consumer spending environment can affect business trends. The development of sensitive-skin products and in-store services presented in filings can contribute to brand differentiation, but actual sales conversion and the operational stability of franchise locations must back them up. Over the medium to long term, the expansion of online sales channels and an improved share of product sales can serve as growth drivers. On the other hand, contraction of the franchise network, an increase in competing products, and weakening consumer sentiment remain factors that can fluctuate revenue and profitability.

🎯 Key growth drivers
Expansion of online sales channels
Franchise partner recruitment and renewals
Improvements to sensitive-skin products

⚔️ Park Ha Biological Technologies core strengths and risks

The combination of brand product development and the franchise network forms the business foundation, and franchise-location changes and shifts in consumer demand are the key risk factors.

💪 Core strengths

Brand and service combination
By offering its own product sales together with in-store follow-up beauty services, it broadens consumer touchpoints.
Franchise operation system
Through training and marketing support for franchise partners, it secures sales touchpoints beyond directly operated stores.
Product improvement capability
Development and improvement functions for products targeting sensitive skin can serve as a basis for product differentiation.

⚠️ Core risks

Franchise-location volatility
Franchise-partner attrition or changes in renewal terms can weigh on franchise fees and brand expansion.
Consumer demand sensitivity
Skincare and cosmetics demand can be affected by consumer sentiment and shifts in market competition.
Channel expansion execution
Continuous verification is needed as to whether the expansion of online sales actually leads to customer acquisition and product sales.

🔄 Park Ha Biological Technologies competitors and related (beneficiary) stocks

For direct competitive comparison, DSY, which manufactures and sells personal-care products, can be used, but because the detailed product lineup differs, caution is needed when comparing. Related names to observe include TANH, which handles household and hygiene products along with bamboo charcoal-based products, and BIOT, which combines regenerative medicine with beauty and wellness. Because these companies have different business structures, it is more appropriate to view them as peripheral indicators around the personal-care and consumer-health theme rather than as direct value comparisons.

Competitors
TickerCompanyPriceChangeMarket CapP/EPBRROEDividend Yield
DSYDSYBig Tree Cloud Holdings Ltd$3.72-3.9%$30.7M-5.0-9117.54%-
Related stocks (beneficiaries)
TickerCompanyPriceChangeMarket CapP/EPBRROEDividend Yield
TANHTANHTantech Holdings Ltd$18.79-14.1%$12.6M0.70.0-25.62%-
BIOTBIOTInstinct Bio Technical Company Holdings Inc$0.39-2.5%$11.1M----

✅ Investor checkpoints for Park Ha Biological Technologies

When reviewing this company, rather than viewing it simply as a product sales company, it is necessary to examine together how franchise fees, in-store services, and online distribution are connected. The stability of franchise partners and the pace of expansion of product sales channels are the core observations for the business structure.

CheckpointWhat to verifyCurrent status
🧴 Product salesVerify that sales of its own skincare and cosmetics products are linked to the brand experience.Reviewing sales flow
🏪 Franchise structureLook at the recruitment, renewals, and attrition trends of franchise partners in filings.Observing renewal terms
💻 Online channelVerify whether the expansion of online sales is translating into customer acquisition and repeat purchases.Confirming execution of expansion

The franchise model can help expand the network, but if changes in the number of partners and a decline in operational quality occur at the same time, this can weigh on revenue and brand trust. In addition, intensifying competition in the personal-care product market and a slowdown in consumer demand can affect both product sales and new franchise recruitment.

Park Ha Biological Technologies has a business structure that combines its own skincare products with franchise operations. Going forward, a conservative approach that looks jointly at the stability of franchise partners, the effectiveness of online sales expansion, and the resilience of product sales will be needed in analysis.

Briefs · earnings · signals, first Subscribe
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →